Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Insulin Pump Market, by Product
1.4.2 LAMEA Insulin Pump Market, by Disease Indication
1.4.3 LAMEA Insulin Pump Market, by Distribution Channel
1.4.4 LAMEA Insulin Pump Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trials and Approvals
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Feb – 2023, Mar) Leading Players
Chapter 4. LAMEA Insulin Pump Market by Product
4.1 LAMEA Pumps Market by Country
4.2 LAMEA Insulin Pump Market by Pumps Type
4.2.1 LAMEA Tethered Market by Country
4.2.2 LAMEA Patch Market by Country
4.2.3 LAMEA Others Market by Country
4.3 LAMEA Consumables Market by Country
Chapter 5. LAMEA Insulin Pump Market by Disease Indication
5.1 LAMEA Type 1 Diabetes Market by Country
5.2 LAMEA Type 2 Diabetes Market by Country
Chapter 6. LAMEA Insulin Pump Market by Distribution Channel
6.1 LAMEA Retail & Online Pharmacies Market by Country
6.2 LAMEA Hospital Pharmacy Market by Country
Chapter 7. LAMEA Insulin Pump Market by Country
7.1 Brazil Insulin Pump Market
7.1.1 Brazil Insulin Pump Market by Product
7.1.1.1 Brazil Insulin Pump Market by Pumps Type
7.1.2 Brazil Insulin Pump Market by Disease Indication
7.1.3 Brazil Insulin Pump Market by Distribution Channel
7.2 Argentina Insulin Pump Market
7.2.1 Argentina Insulin Pump Market by Product
7.2.1.1 Argentina Insulin Pump Market by Pumps Type
7.2.2 Argentina Insulin Pump Market by Disease Indication
7.2.3 Argentina Insulin Pump Market by Distribution Channel
7.3 UAE Insulin Pump Market
7.3.1 UAE Insulin Pump Market by Product
7.3.1.1 UAE Insulin Pump Market by Pumps Type
7.3.2 UAE Insulin Pump Market by Disease Indication
7.3.3 UAE Insulin Pump Market by Distribution Channel
7.4 Saudi Arabia Insulin Pump Market
7.4.1 Saudi Arabia Insulin Pump Market by Product
7.4.1.1 Saudi Arabia Insulin Pump Market by Pumps Type
7.4.2 Saudi Arabia Insulin Pump Market by Disease Indication
7.4.3 Saudi Arabia Insulin Pump Market by Distribution Channel
7.5 South Africa Insulin Pump Market
7.5.1 South Africa Insulin Pump Market by Product
7.5.1.1 South Africa Insulin Pump Market by Pumps Type
7.5.2 South Africa Insulin Pump Market by Disease Indication
7.5.3 South Africa Insulin Pump Market by Distribution Channel
7.6 Nigeria Insulin Pump Market
7.6.1 Nigeria Insulin Pump Market by Product
7.6.1.1 Nigeria Insulin Pump Market by Pumps Type
7.6.2 Nigeria Insulin Pump Market by Disease Indication
7.6.3 Nigeria Insulin Pump Market by Distribution Channel
7.7 Rest of LAMEA Insulin Pump Market
7.7.1 Rest of LAMEA Insulin Pump Market by Product
7.7.1.1 Rest of LAMEA Insulin Pump Market by Pumps Type
7.7.2 Rest of LAMEA Insulin Pump Market by Disease Indication
7.7.3 Rest of LAMEA Insulin Pump Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Tandem Diabetes Care, Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Trials and Approvals:
8.2 SOOIL Developments Co., Ltd
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.3 Jiangsu Delfu Medical Device Co.,Ltd
8.3.1 Company Overview
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Insulet Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Trials and Approvals:
8.6.5.3 Acquisition and Mergers:
8.6.5.4 Geographical Expansions:
8.7 Ypsomed AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.8 Aetna, Inc. (CVS Pharmacy, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.9 Diabeloop SA
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. APEX Medical Corporation
8.10.1 Company Overview
Unique Offerings 